Literature DB >> 25143228

[Non-invasive treatment of tachycardias during childhood].

Jan-Hendrik Nürnberg1, Joachim Hebe, Jürgen Siebels.   

Abstract

In principle tachycardias during childhood do not differ from those in adulthood but they present with a significant age-dependency. Additionally the clinical presentation has a broad spectrum related to the different ages, from the neonatal period until adolescence. If congenital heart disease is present the hemodynamic compromise may be accentuated. This paper describes the diagnostic and therapeutic approaches to pediatric tachycardias with focus upon the age dependent aspects and the presense of congenital heart disease, either native or postoperative.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25143228     DOI: 10.1007/s00399-014-0339-1

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN: 0938-7412


  31 in total

Review 1.  Adenosine: an effective and safe antiarrhythmic drug in pediatrics.

Authors:  T Paul; J P Pfammatter
Journal:  Pediatr Cardiol       Date:  1997 Mar-Apr       Impact factor: 1.655

Review 2.  Verapamil: an effective calcium blocking agent for pediatric patients.

Authors:  C J Porter; A Garson; P C Gillette
Journal:  Pediatrics       Date:  1983-05       Impact factor: 7.124

3.  Physiologically based pharmacokinetic models in the prediction of oral drug exposure over the entire pediatric age range-sotalol as a model drug.

Authors:  Feras Khalil; Stephanie Läer
Journal:  AAPS J       Date:  2014-01-08       Impact factor: 4.009

4.  Sudden cardiac death in adult congenital heart disease.

Authors:  Zeliha Koyak; Louise Harris; Joris R de Groot; Candice K Silversides; Erwin N Oechslin; Berto J Bouma; Werner Budts; Aeilko H Zwinderman; Isabelle C Van Gelder; Barbara J M Mulder
Journal:  Circulation       Date:  2012-09-18       Impact factor: 29.690

5.  Arrhythmias in patients with hypoplastic left heart syndrome.

Authors:  Bhavya Trivedi; P Brian Smith; Piers C A Barker; James Jaggers; Andrew J Lodge; Ronald J Kanter
Journal:  Am Heart J       Date:  2011-01       Impact factor: 4.749

6.  Development of a safe and effective pediatric dosing regimen for sotalol based on population pharmacokinetics and pharmacodynamics in children with supraventricular tachycardia.

Authors:  Stephanie Läer; Jan-Peer Elshoff; Bernd Meibohm; Jochen Weil; Thomas S Mir; Wenhui Zhang; Martin Hulpke-Wette
Journal:  J Am Coll Cardiol       Date:  2005-10-04       Impact factor: 24.094

7.  Flecainide acetate for resistant arrhythmias in the young: efficacy and pharmacokinetics.

Authors:  J C Perry; R L McQuinn; R T Smith; C Gothing; P Fredell; A Garson
Journal:  J Am Coll Cardiol       Date:  1989-07       Impact factor: 24.094

8.  Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide. The Pediatric Electrophysiology Group.

Authors:  F A Fish; P C Gillette; D W Benson
Journal:  J Am Coll Cardiol       Date:  1991-08       Impact factor: 24.094

9.  Cardiac decompensation following verapamil therapy in infants with supraventricular tachycardia.

Authors:  M L Epstein; E A Kiel; B E Victorica
Journal:  Pediatrics       Date:  1985-04       Impact factor: 7.124

10.  Frequency of recurrence among infants with supraventricular tachycardia and comparison of recurrence rates among those with and without preexcitation and among those with and without response to digoxin and/or propranolol therapy.

Authors:  Tia A Tortoriello; Christopher S Snyder; E O'Brian Smith; Arnold L Fenrich; Richard A Friedman; Naomi J Kertesz
Journal:  Am J Cardiol       Date:  2003-11-01       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.